Tetra Radar · FDA Approvals · Decision date
Zai Lab Ltd: FDA decision date
Zai Lab Ltd (ZLAB) · 10 May 2026
In January 2026, the FDA accepted for priority review an sBLA submitted by argenx seeking expansion of the VYVGART label to include adult AChR-Ab sn-gMG patients with a PDUFA target action date of May 10, 2026.
Source: 10-Q of 7 May 2026
The date has passed; Tetra Radar has not recorded an approval.
A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.